Synthesis and biological evaluation of 4-(4-aminophenyl)-6-methylisoxazolo[3,4-b] pyridin-3-amine covalent inhibitors as potential agents for the treatment of acute myeloid leukemia.
Kang JB, Chen L, Leng XJ, Wang JJ, Cheng Y, Wu SH, Ma YY, Yang LJ, Cao YH, Yang X, Tong ZJ, Wu JZ, Wang YB, Zhou H, Liu JC, Ding N, Dai WC, Yu YC, Xue X, Sun SL, Dai XB, Chang L, Wang XL, Li NG, Shi ZH.
Kang JB, et al. Among authors: xue x.
Bioorg Med Chem. 2022 Sep 15;70:116937. doi: 10.1016/j.bmc.2022.116937. Epub 2022 Jul 16.
Bioorg Med Chem. 2022.
PMID: 35863236